Newly Approved Drug Illuminates Ovarian Cancer Tissue
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Newly Approved Drug Illuminates Ovarian Cancer Tissue
-
Narrated by:
-
By:
About this listen
The U.S. Food and Drug Administration (FDA) approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons to more easily find and more precisely remove cancer.
adbl_web_global_use_to_activate_webcro805_stickypopup
No reviews yet